Last reviewed · How we verify
NCT04038190
A Behavioral Activation Intervention Administered in a College Freshman Orientation Course
Phase 2 trial testing behavioral activation in Alcohol; Use, Problem in 540 participants. Status unknown.
30 June 2025
Quick facts
| Lead sponsor | University of Kansas |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 540 |
| Start date | 5 September 2019 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- behavioral activation
Conditions studied
- Alcohol; Use, Problem — all drugs for Alcohol; Use, Problem →
- Stress — all drugs for Stress →
- Binge Eating — all drugs for Binge Eating →
- Depression — all drugs for Depression →
Sponsor
University of Kansas
Who can join
17 and older, any sex, with Alcohol; Use, Problem or Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The transition from high school to college is a developmentally sensitive period that is high risk for escalations in alcohol use. Although risky drinking is a common problem among freshmen, engagement in treatment services is very low. The proposed study will test a behavioral activation intervention that addresses factors limiting participation in standard treatment services by targeting alcohol use indirectly, by directly addressing concerns most relevant to incoming college freshmen, and by integrating an intervention into the college curriculum.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Engagement with Activity Monitoring During a Behavioral Activation Intervention: A Randomized Test of Monitoring Format and Qualitative Evaluation of Participant Experiences.
Fazzino TL, Kunkel A, Bellitti J, Romine RS, et al · · 2023 · cited 2× · PMID 37583941 · DOI 10.1017/bec.2022.7 -
A behavioral activation intervention administered in a 16-week freshman orientation course: Study protocol.
Fazzino TL, Lejuez CW, Yi R. · · 2020 · cited 1× · PMID 31982647 · DOI 10.1016/j.cct.2020.105950
Verify or expand the search:
- PubMed search for NCT04038190
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of behavioral activation
Trials testing the same drug.
- NCT06348940 — Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patient · NA · active not recruiting
- NCT05764148 — Effectiveness of Behavioral Activation Treatment for Schizophrenia · NA · unknown
Other recruiting trials for Alcohol; Use, Problem
Currently open trials in the same condition.
- NCT06278922 — Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma · NA · recruiting
- NCT04124380 — Understanding and Testing Recovery Processes for PTSD and Alcohol Use Following Sexual Assault · NA · active not recruiting
Other University of Kansas trials
Trials by the same sponsor.
- NCT07060534 — Building Healthy Eating and Self-Esteem Together for University Students · NA · recruiting
- NCT07301060 — Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control · NA · recruiting
- NCT07283510 — Community-based Functional Fitness for Adults Aging With Mobility Disability · NA · completed
- NCT05190926 — Smart Technology for Anorexia Nervosa Recovery · NA · unknown
- NCT05880966 — Functional Fitness for Overweight or Obese Adults with Mobility Disabilities · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04038190 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Kansas
- Last refreshed: 24 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038190.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing